[Clinical studies on PC-904 in biliary tract diseases (author's transl)]. 1979

K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi

The clinical effects of PC-904, a new semisynthetic penicillin, were studied in patients with biliary tract diseases, and the results were as follows: 1) PC-904 showed an average peak serum level of 40.7 +/- 11.6 microgram/ml 2 hours after an intravenous drip infusion of 1 g of the agent. The biliary level showed a peak value of 126.5 +/- 85.4 microgram/ml 2 hours to 3 hours after the infusion. 2) Isolated organisms from bile before the treatment were E. coli, Klebsiella, Proteus, Pseudomonas, Enterococcus and Bacteroides. MIC of PC-904 on 18 strains of isolated organisms was almost 6.25 microgram/ml or less. All isolated organisms except one strain of Klebsiella oxytoca disappeared after the treatment. 3) Six patients with cholelithiasis were medicated with PC-904 to prevent post-operative infections. The clinical effects were good in 4, poor in 1 and unknown in 1 case. 4) As to side effects no adverse reactions and allergic reactions were noted. Also no significant abnormalities of laboratory findings were observed.

UI MeSH Term Description Entries
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001659 Biliary Tract The BILE DUCTS and the GALLBLADDER. Biliary System,Biliary Tree,System, Biliary,Tract, Biliary,Tree, Biliary
D001660 Biliary Tract Diseases Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER. Biliary Tract Disease,Disease, Biliary Tract,Diseases, Biliary Tract,Tract Disease, Biliary,Tract Diseases, Biliary

Related Publications

K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
March 1979, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
K Ohhara, and H Kubota, and H Hashiba, and T Kohchi, and T Urushibara, and N Kikuchi, and T Yotsumoto, and K Itoh, and K Ichimura, and T Uchida, and A Kobayashi, and H Kanno, and N Kikuchi
July 1978, The Japanese journal of antibiotics,
Copied contents to your clipboard!